WeightWatchers gets into prescription weight loss business

  • 📰 CTVNews
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 99%

Nederland Nieuws Nieuws

Nederland Laatste Nieuws,Nederland Headlines

WeightWatchers soared Tuesday after the company said it was getting into the prescription drug weight loss business with the acquisition of Sequence.

Sequence, a telehealth operator, says that its specialists can prescribe medications under brand names including Ozempic, Wegovy and Trulicity.WeightWatchers offers subscribers meal plans with the goal of losing excess weight. With the acquisition of Sequence, the company is tapping into a red-hot market for prescription drugs that addresses obesity, and broadening what it offers to customers.

Ozempic, also known as semaglutide, works by stimulating the body's own insulin production and reducing appetite. While it is prescribed for diabetes, Ozempic can also help people lose weight. "This deal brings access to prescription drug solutions for weight loss to WW's historical focus on behavior modification model," wrote UBS analyst Michael Lasser. "This is a significant change in the business. While the deal could bring considerable upside, it also carries sizable risks,"

Wij hebben dit nieuws samengevat zodat u het snel kunt lezen. Bent u geïnteresseerd in het nieuws, dan kunt u hier de volledige tekst lezen. Lees verder:

 /  🏆 1. in NL
 

Bedankt voor uw reactie. Uw reactie wordt na beoordeling gepubliceerd.

Fantastic, more drug pushers!

There is always a pill for that 🙃🤣

Nederland Laatste Nieuws, Nederland Headlines

Similar News:Je kunt ook nieuwsberichten lezen die vergelijkbaar zijn met deze die we uit andere nieuwsbronnen hebben verzameld.

Market movers: Stocks seeing action on Tuesday - and whyA look at North American equities heading in both directions
Bron: globeandmail - 🏆 5. / 92 Lees verder »